Uncategorized - July 15, 2022
NNF awards grant for establishing Diabetes and Endocrine Academy
The Novo Nordisk Foundation (NNF) has awarded a 195 million DKK grant for establishing a national, brickless Danish Diabetes and Endocrine Academy (DDEA) with an executive office based at Odense University Hospital. The purpose of the Academy is to develop and strengthen the quality of Danish diabetes and endocrine research and research-based education. The Academy […]
Financing - April 21, 2022
The Novo Nordisk Foundation announces new 2030 plan
The Novo Nordisk Foundation (NNF) will focus on three key themes in the years to 2030, people’s health, the sustainability of society and the planet and boosting Denmark’s life science ecosystem. “The COVID-19 pandemic, the world-wide spread of diabetes and the climate changes emphasize the need for a global effort to safeguard people’s health and […]
COVID-19 - March 16, 2022
Initiative supporting new antiviral medicines for future pandemics launched
The Novo Nordisk Foundation, Open Philanthropy, and the Bill & Melinda Gates Foundation have announced an initial commitment of up to 90 million USD of coordinated funding toward Pandemic Antiviral Discovery (PAD). PAD is a new initiative to catalyze discovery and early development of antiviral medicines for future pandemics. With equitable access as a core […]
Business article - February 7, 2022
NNF expands its innovation grants to applicants from any Nordic country
Until 2021, only researchers based in Denmark were eligible to receive the Novo Nordisk Foundation (NNF)’s grants under the Distinguished Innovator programme, but from 2022 researchers in any Nordic country (Denmark, Finland, Iceland, Norway and Sweden) are eligible. These grants support research within life science and aim to stimulate innovation and entrepreneurship at universities by […]
Careers article - January 17, 2022
New programme aims to bridge the gap between academia and business
The innovation programme SPARK Denmark will also help to strengthen Denmark’s talent pipeline and provides a major career boost for individual researchers and innovators. SPARK Denmark is being established at Denmark’s five largest universities based on a grant of 44 million DKK from the Novo Nordisk Foundation. SPARK aims to improve the translation of promising […]
Business article - April 12, 2021
Strong foundation for Danish life sciences
The Novo Nordisk Foundation has supported Danish life sciences for almost 100 years, maintaining knowledge, technology, talent and companies in the region. You can not really speak about life sciences in Denmark without mentioning its large industrial foundations and how they have benefited the industry. These long-term investors have benefited both the pharma and biotech […]
